Literature DB >> 12076670

The fragile X premutation: into the phenotypic fold.

Randi J Hagerman1, Paul J Hagerman.   

Abstract

Premutation alleles (55-200 CGG repeats) of the fragile X mental retardation 1 gene (FMR1) are known to contribute to the fragile X phenotype through genetic instability and transmission of full mutation alleles (>200 repeats). There is now mounting evidence that the premutation alleles themselves contribute to clinical involvement, including premature ovarian failure among female carriers and a new tremor/ataxia syndrome among older male carriers. Recent observations also provide direct evidence of dysregulation of the FMR1 gene in the premutation range, which may explain many of the clinical observations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12076670     DOI: 10.1016/s0959-437x(02)00299-x

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  98 in total

Review 1.  Imaging of neurogenetic and neurometabolic disorders of childhood.

Authors:  Andrea Gropman
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

2.  Physiological regulation and social-emotional processing in female carriers of the FMR1 premutation.

Authors:  Molly Winston; Kritika Nayar; Abigail L Hogan; Jamie Barstein; Chelsea La Valle; Kevin Sharp; Elizabeth Berry-Kravis; Molly Losh
Journal:  Physiol Behav       Date:  2019-11-22

3.  Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia.

Authors:  Elena Martín-González; Ángeles Prados-Pardo; Santiago Mora; Pilar Flores; Margarita Moreno
Journal:  Psychopharmacology (Berl)       Date:  2018-01-08       Impact factor: 4.530

4.  Fragile X mental retardation protein (FMRP) and the spinal sensory system.

Authors:  Theodore J Price; Ohannes K Melemedjian
Journal:  Results Probl Cell Differ       Date:  2012

5.  FMR1 premutation as a rare cause of late onset ataxia--evidence for FXTAS in female carriers.

Authors:  Ch Zühlke; A Budnik; U Gehlken; A Dalski; S Purmann; M Naumann; M Schmidt; K Bürk; E Schwinger
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

Review 6.  A review of fragile X premutation disorders: expanding the psychiatric perspective.

Authors:  James A Bourgeois; Sarah M Coffey; Susan M Rivera; David Hessl; Louise W Gane; Flora Tassone; Claudia Greco; Brenda Finucane; Lawrence Nelson; Elizabeth Berry-Kravis; Jim Grigsby; Paul J Hagerman; Randi J Hagerman
Journal:  J Clin Psychiatry       Date:  2009-05-05       Impact factor: 4.384

Review 7.  Reversing neurodevelopmental disorders in adults.

Authors:  Dan Ehninger; Weidong Li; Kevin Fox; Michael P Stryker; Alcino J Silva
Journal:  Neuron       Date:  2008-12-26       Impact factor: 17.173

8.  Prevalence of CGG expansions of the FMR1 gene in a US population-based sample.

Authors:  Marsha Mailick Seltzer; Mei Wang Baker; Jinkuk Hong; Matthew Maenner; Jan Greenberg; Daniel Mandel
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-22       Impact factor: 3.568

9.  Expansion of an FMR1 grey-zone allele to a full mutation in two generations.

Authors:  Isabel Fernandez-Carvajal; Blanca Lopez Posadas; Ruiqin Pan; Christopher Raske; Paul J Hagerman; Flora Tassone
Journal:  J Mol Diagn       Date:  2009-06-12       Impact factor: 5.568

10.  A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome.

Authors:  Stela Filipovic-Sadic; Sachin Sah; Liangjing Chen; Julie Krosting; Edward Sekinger; Wenting Zhang; Paul J Hagerman; Timothy T Stenzel; Andrew G Hadd; Gary J Latham; Flora Tassone
Journal:  Clin Chem       Date:  2010-01-07       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.